Hadar Ilan
Insider CIK 1727727 · MNLO CFO and Country Manager · FOMX CFO & Country Manager · SLXN Chairman and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SLXN Silexion Therapeutics Corp | A Award | 2026-06-04 | 2026-06-08 | 10,000 | — | $0 | 16,547 | SEC↗ |
| SLXN Silexion Therapeutics Corp | A Award | 2026-02-20 | 2026-02-23 | 64,350 | — | $0 | 65,471 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 5,469 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 24,125 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 18,000 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 202,004 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 60,000 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 60,389 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 196,205 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 35,093 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 96,365 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 94,996 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 35,774 | — | $0 | 35,774 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 116,231 | — | $0 | 116,231 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 20,789 | — | $0 | 20,789 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 56,275 | — | $0 | 56,275 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 3,239 | — | $0 | 3,239 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 14,291 | — | $0 | 14,291 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 10,663 | — | $0 | 10,663 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 119,667 | — | $0 | 119,667 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 35,544 | — | $0 | 35,544 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 57,086 | — | $0 | 57,086 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer | 2020-03-09 | 2020-03-11 | 14,077 | — | $0 | 116,501 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer | 2020-03-09 | 2020-03-11 | 116,501 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-03-09 | 2020-03-11 | 69,012 | — | $0 | 77,351 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-03-09 | 2020-03-11 | 8,339 | — | $0 | 8,339 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award deriv | 2020-02-24 | 2020-02-24 | 96,365 | — | $0 | 96,365 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award | 2020-02-24 | 2020-02-24 | 41,299 | — | $0 | 130,578 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | S Sale | 2019-09-10 | 2019-09-11 | 34,392 | $3.50 | $120.4K | 89,279 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | S Sale | 2019-09-09 | 2019-09-11 | 9,420 | $3.50 | $33.0K | 123,671 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award deriv | 2019-01-01 | 2019-01-03 | 94,996 | $3.81 | $361.9K | 94,996 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award | 2019-01-01 | 2019-01-03 | 40,712 | — | $0 | 133,091 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award deriv | 2018-02-27 | 2018-02-28 | 35,093 | $6.40 | $224.6K | 35,093 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award | 2018-02-27 | 2018-02-28 | 11,698 | — | $0 | 92,379 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | M Exercise deriv | 2018-01-15 | 2018-01-24 | 562 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | M Exercise | 2018-01-15 | 2018-01-24 | 562 | — | $0 | 80,681 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | M Exercise deriv | 2018-01-01 | 2018-01-24 | 5,032 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | M Exercise | 2018-01-01 | 2018-01-24 | 5,032 | — | $0 | 80,681 | SEC↗ |